NCT03190603View on ClinicalTrials.gov

Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

June 5, 2018

Study Completion Date

June 5, 2018

Conditions

SpondylarthropathiesMagnetic Resonance Imaging

Interventions

DRUG

Celecoxib

Continue celecoxib 400mg/day for 3months in axial spondyloarthritis patients.

Trial Locations (1)

KS009

Armed Forces Capital Hospital, Seongnam-si

All Listed Sponsors

lead

Armed Forces Capital Hospital, Republic of Korea

OTHER_GOV

NCT03190603 - Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis | Biotech Hunter | Biotech Hunter